Alnylam to webcast investor event to discuss results from KARDIA-2 phase 2 study of zilebesiran at American College of Cardiology Scientific Session

Dear Investor,

Please find below link to a press release from our partner company Alnylam:
https://investors.alnylam.com/press-release?id=28071

We kindly invite you to join this investor event on Sunday April 7, 2024 at 7:00 pm ET.

Do not hesitate to contact us for any further questions.

With best regards,

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com